Search

The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2021

Congress

… The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2021 The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2021 ProQR to participate in the …

May 02, 2021
ARVO Annual Meeting

Congress

Annual meeting of the Association for Research in Vision and Ophthalmology in Denver, CO, U.S.

May 01, 2022
ARVO (2021) Russell SR et al., Safety and efficacy of sepofarsen in the second treated eye in a Ph1b/2 extension trial in Leber Congenital Amaurosis type 10 (LCA10)

Presentation

ARVO 2021 presentation by Stephen R. Russell from Iowa University on the Safety and efficacy of sepofarsen in the second treated eye in a Ph1b/2 extension trial in CEP290 mediated Leber Congenital Amaurosis type 10.

May 06, 2021
Results of a phase 1b/2 trial of intravitreal (IVT) sepofarsen (QR-110) antisense oligonucleotide in Leber congenital amaurosis 10 (LCA10) due to p.Cys998X mutation in the CEP290 gene

Presentation

ARVO 2020 clinical trial results presentation by Stephen Russel et al. Sepofarsen had a manageable safety profile and showed improvement in mean visual acuity, and full-field stimulus testing.

June 17, 2020